Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06190730 · ClinicalTrials.gov registry record · NA

REmote Symptom COllection to improVE postopeRative Care

A NA study of Gastrointestinal Cancer and Gastrointestinal Tumor, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
NA
Development phase
281
Enrollment target
2
Study locations

NCT06190730: Recruiting NA study of Gastrointestinal Cancer and Gastrointestinal Tumor, sponsored by Medstar Health Research Institute.

NCT06190730 is a NA study of Gastrointestinal Cancer and Gastrointestinal Tumor that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 281 participants, above the 224-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (25% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06190730, a NA study of Gastrointestinal Cancer and Gastrointestinal Tumor, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
NA
Development phase
281 participants
Enrollment target
2
Study locations

Study Summary

There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.

Primary Outcome

Daily symptom-based self-reported assessment on dyspnea, fever, melena, pain, wound healing, activities of daily living, sensorium, gastrointestinal motility, dysphagia, pitting edema, mood, and an option to mention symptoms not asked of. This is monitored by the research team, and any concerning finding, at the discretion of the site's physician, will be relayed to the subject's treating physician. Treating physician has final decision on whether to address referral by adjustment of managemen

Interventions

  • OTHER Voice-Assisted Remote Symptom Monitoring System (VARSMS)

Study Locations (2)

Maryland

  • MedStar Health - Baltimore

Nebraska

  • Creighton University - Omaha

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2024-07-23
Est. Completion 2027-12-31
Phase NA
Medstar Health Research Institute

115 total trials

What NCT06190730 shows while recruiting

NCT06190730 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, above the 224-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (25% higher).

The record links to 4 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Voice-Assisted Remote Symptom Monitoring System (VARSMS) is the first listed.

NCT06190730 reports a single indexed study location in Maryland, Nebraska.

Frequently Asked Questions

What is clinical trial NCT06190730 about?

NCT06190730 is a clinical study titled "REmote Symptom COllection to improVE postopeRative Care". There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.

What is the current status of trial NCT06190730?

This trial is currently recruiting. It is a NA study. The enrollment target is 281 participants. The study started on 2024-07-23. Estimated completion is 2027-12-31.

What conditions does trial NCT06190730 study?

This clinical trial studies the following conditions: Gastrointestinal Cancer, Gastrointestinal Tumor, Gastrointestinal Tumor Surgery, Gastrointestinal Surgery.

What interventions are being tested in trial NCT06190730?

The interventions under investigation include: Voice-Assisted Remote Symptom Monitoring System (VARSMS) (OTHER).

Who is sponsoring clinical trial NCT06190730?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06190730 being conducted?

This trial has 2 study locations across Maryland, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06190730's enrollment target sits among peer trials

281 10th of 49 higher than 40 of 49 other Gastrointestinal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastrointestinal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04521231 · 281 participants · Phase 1

    A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

  • NCT05101070 · 282 participants · Phase 1

    S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06190730, the US trial registry maintained by the National Library of Medicine. NCT06190730 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.